uses JavaScript to provide the best possible experience for our content, but your browser has it disabled. Learn how to enable it here.


Posted July 7, 2020

Seller of Homeopathic Products Warned for Manufacturing Violations

On June 19, 2020, the FDA issued a warning letter to Washington Homeopathic Products, Inc. which found the company's products, including Apis Mellifica, Aceticum acidum, Colchicum, Natrum Sulphuricum, Sasaparilla, Aconitum Napellus, and Veratrum Album, to be adulterated because they were prepared, packed, or held under conditions that violate Current Good Manufacturing Practices for dietary supplements.

These violations include failure establish an adequate quality control unit, failure to test the identity of each drug component in a product, and failure to establish and document the accuracy, sensitivity, specificity, and reproducibility of test methods, as required by federal regulations.

In addition, statements made about these products were found to be drug claims. For example, Apis Mellifica was promoted with statements such as "Apis has proved [sic] a curative remedy, has often cured tumors, and has caused cystic formation to stop growing or to disappear," and Aceticum acidum was promoted with statements such as "antidote to... Stomach, cancer of... It is suited to children and old people."

See related recalls and warnings:

Seller of Tea, Colloidal Silver, Homeopathic Products Warned for Manufacturing Violations

Homeopathic Company Warned For Drug Claims and Improper Labeling

BioPure Healing Products Warned for Manufacturing Violations

Seller of Silver, Arginine, and More Warned for Manufacturing Violations

For more information, use the link below: